Literature DB >> 16581973

Human cardiac myosin autoantibodies impair myocyte contractility: a cause-and-effect relationship.

Rahat S Warraich1, Elinor Griffiths, Andrew Falconar, Vijay Pabbathi, Chris Bell, Gianni Angelini, M-Saadeh Suleiman, Magdi H Yacoub.   

Abstract

The functional relevance of autoantibodies (Abs) against cardiac myosin (CM) in clinical idiopathic dilated cardiomyopathy (DCM) remains controversial. The study sought to determine effects of human Abs affinity-purified (AF) by immunoaffinity column chromotography on excitation-contraction coupling in isolated myocytes. Effects of CM-Abs from heart failure patients with DCM (n=19) and ischemic heart disease (IHD, n=19) on contractility, L-type Ca2+ current, and Ca2+ transients in continuously perfused rat ventricular myocytes were studied. Immunofluorescence studies using confocal microscopy were carried out to determine whether Abs were internalized. AF-Abs from either group did not differ in IgG titer but differed in their elution profiles. The IgG3 subclass response was higher in AF fractions from DCM (21%) than IHD (5%) patients. The Abs reduced the capacity of field-stimulated myocytes to contract in a dose-dependent manner. Inhibition of contraction, as a percentage of untreated cells, was greater with DCM than IHD-Abs (P=0.004), and the effect was independent of Ab titer. An increase in frequency of the beating myocytes (0.2 to 3.0 Hz) raised peak systolic and diastolic levels of [Ca2+]i of cells treated with DCM but not IHD-Abs (P<0.005). The AF-Abs were not internalized by myocytes and had no effect on L-type Ca2+ currents. The altered sensitivity of the myofilaments to [Ca2+]i by CM-Abs may represent a potential mechanism of autoantibody-mediated impairment in clinical DCM.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16581973     DOI: 10.1096/fj.04-3001com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  9 in total

1.  Induction of cardiomyocyte apoptosis by anti-cardiac myosin heavy chain antibodies in patients with acute myocardial infarction.

Authors:  Kun Liu; Liang Shao; Li Wang; Yanping Ding; Guanhua Su; Jue Wang; Yuhua Liao; Zhaohui Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-11-10

Review 2.  Autoantibodies and cardiovascular dysfunction: cause or consequence?

Authors:  Yuji Nagatomo; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2014-12

Review 3.  The clinical and diagnostic significance of anti-myosin autoantibodies in cardiac disease.

Authors:  Udi Nussinovitch; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2013-02       Impact factor: 8.667

4.  Presence of circulating anti-myosin antibodies in endomyocardial fibrosis.

Authors:  Ana Olga Mocumbi; Najma Latif; Magdi H Yacoub
Journal:  PLoS Negl Trop Dis       Date:  2010-04-20

Review 5.  The role of B-cells in heart failure.

Authors:  Andrea M Cordero-Reyes; Keith A Youker; Guillermo Torre-Amione
Journal:  Methodist Debakey Cardiovasc J       Date:  2013 Jan-Mar

6.  Autoantibodies and Cardiomyopathy: Focus on Beta-1 Adrenergic Receptor Autoantibodies.

Authors:  Wai Hong Wilson Tang; Sathyamangla V Naga Prasad
Journal:  J Cardiovasc Pharmacol       Date:  2022-09-01       Impact factor: 3.271

Review 7.  Lymphocytic subsets play distinct roles in heart diseases.

Authors:  Jing Wang; Yi Duan; Joost Pg Sluijter; Junjie Xiao
Journal:  Theranostics       Date:  2019-05-31       Impact factor: 11.556

Review 8.  Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management.

Authors:  Alida L P Caforio; Renzo Marcolongo; Roland Jahns; Michael Fu; Stephan B Felix; S Iliceto
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.654

Review 9.  The role of B cells in heart failure and implications for future immunomodulatory treatment strategies.

Authors:  Gerardo García-Rivas; Elena Cristina Castillo; Adrian M Gonzalez-Gil; José Luis Maravillas-Montero; Marion Brunck; Alejandro Torres-Quintanilla; Leticia Elizondo-Montemayor; Guillermo Torre-Amione
Journal:  ESC Heart Fail       Date:  2020-06-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.